supported by National Natural Science Foundation of China 81872915(MWI),82073904(MW),82121005(DY),81973373(DY),21704064(QZ);National Science&Technology Major Project of China-Key New Drug Creation and Manufacturing Program 2018ZX09735-001(MW),2018ZX09711002-002-005(DY);National Science&Technology Major Project of China-Innovation 2030 for Brain Science and Brain-Inspired Technology 2021ZD0203400(QZ);the National Key Basic Research Program of China 2018YFA0507000(MW);Novo Nordisk-CAS Research Fund grant NNCAS-2017-1-CC(DY)and SA-SIBS Scholarship Program(IDY).
The paradigm of one drug against multiple targets,known as unimolecular polypharmacology,offers the potential to improve efficacy while overcoming some adverse events associated with the treatment.This approach is bes...
This work was supported by AR056246(F.Y.L.),AR068353(F.Y.L.),and CA203011(F.Y.L).
Disruption of bone homeostasis caused by metastatic osteolytic breast cancer cells increases inflammatory osteolysis and decreases bone formation,thereby predisposing patients to pathological fracture and cancer growt...